Maria Weber

427 total citations
23 papers, 253 citations indexed

About

Maria Weber is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Maria Weber has authored 23 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Infectious Diseases. Recurrent topics in Maria Weber's work include Drug Transport and Resistance Mechanisms (11 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Maria Weber is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Maria Weber collaborates with scholars based in Austria, France and Switzerland. Maria Weber's co-authors include Markus Zeitlinger, Spencer B. Gay, B Williamson, Oliver Langer, Martin Bauer, Marcus Hacker, Walter Jäger, Nicolas Tournier, Wolfgang Wadsak and Rudolf Karch and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Journal of Antimicrobial Chemotherapy and Radiographics.

In The Last Decade

Maria Weber

20 papers receiving 245 citations

Peers

Countries citing papers authored by Maria Weber

Since Specialization

Citations

This map shows the geographic impact of Maria Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Weber more than expected).

Fields of papers citing papers by Maria Weber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Weber. The network helps show where Maria Weber may publish in the future.

Co-authorship network of co-authors of Maria Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Weber. A scholar is included among the top collaborators of Maria Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Weber. Maria Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of solnatide to treat pulmonary permeability edema in SARS-CoV-2 positive patients with moderate to severe ARDS: A randomized controlled pilot-trial 2025 ·Anaesthesia Critical Care & Pain Medicine ·Katharina Krenn, (unknown), Matthias Urban, Roman Ullrich, (unknown), Georg Gelbenegger, Martin Bauer, (unknown), (unknown), Anselm Jorda, Maria Weber, Arschang Valipour, Franz König, Rudolf Lucas, (unknown)	0
2	A Pilot Study on the Impact of Cranberry and Ascorbic Acid Supplementation on the Urinary Microbiome of Healthy Women: A Randomized Controlled Trial 2025 ·Antibiotics ·(unknown), Bela Hausmann, Maria Weber, Petra Pjevac, David Berry, Markus Zeitlinger	1
3	Immunogenicity, safety, and reactogenicity of concomitant administration of the novavax vaccine against Omicron XBB.1.5 (NVX-CoV2601) and a 20-valent pneumococcal conjugate vaccine in adults aged ≥60 years: A randomised, double-blind, placebo-controlled, non-inferiority trial 2025 ·Journal of Infection ·Anselm Jorda, (unknown), (unknown), (unknown), (unknown), (unknown), Erdem Yıldız, (unknown), Maria Weber, (unknown), (unknown), (unknown), (unknown), (unknown), Ursula Wiedermann, Lukas Weseslindtner, Monika Redlberger‐Fritz, Felix Bergmann, Markus Zeitlinger	1
4	Effect of probenecid on the whole-body disposition of 6-bromo-7-[11C]methylpurine in humans assessed with long axial field-of-view PET/CT 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Severin Mairinger, Ivo Rausch, Maria Weber, (unknown), Lukas Nics, Werner Langsteger, Markus Zeitlinger, (unknown), Oliver Langer	0
5	Single‐dose and steady‐state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug–drug interaction study 2024 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), Martin Bauer, Iris K. Minichmayr, Birgit Reiter, (unknown), (unknown), Maria Weber, (unknown), Marie Spies, Maysa Sarhan, (unknown), (unknown), (unknown), Markus Zeitlinger	0
6	First-in-human evaluation of 6-bromo-7-[11C]methylpurine, a PET tracer for assessing the function of multidrug resistance-associated proteins in different tissues 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·Severin Mairinger, (unknown), (unknown), Ivo Rausch, Maria Weber, (unknown), (unknown), Lukas Nics, Jens Pahnke, Werner Langsteger, (unknown), Markus Zeitlinger, Oliver Langer	2
7	[11C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patients 2024 ·Fluids and Barriers of the CNS ·(unknown), (unknown), (unknown), Severin Mairinger, Maria Weber, (unknown), (unknown), Ivo Rausch, (unknown), Marcus Hacker, S. Rodrigo, Viviane Bouilleret, Markus Zeitlinger, Ekaterina Pataraia, Nicolas Tournier, Martin Bauer, Oliver Langer	3
8	St. John's wort extract with a high hyperforin content does not induce P‐glycoprotein activity at the human blood–brain barrier 2024 ·Clinical and Translational Science ·(unknown), (unknown), (unknown), Severin Mairinger, Maria Weber, (unknown), Stefan Poschner, Ivo Rausch, (unknown), (unknown), Walter Jäger, (unknown), Nicolas Tournier, Marcus Hacker, Markus Zeitlinger, Martin Bauer, Oliver Langer	5
9	Revisiting the role of endogenous STAT3 in HPV‐positive cervical cancer cells 2023 ·Journal of Medical Virology ·(unknown), Maria Weber, (unknown), Angela Holzer, Karin Hoppe‐Seyler, Felix Hoppe‐Seyler	5
10	Bacterial growth and ceftriaxone activity in individual ascitic fluids in an in vitro model of spontaneous bacterial peritonitis 2023 ·Frontiers in Pharmacology ·(unknown), Beatrix Wulkersdorfer, (unknown), (unknown), Philipp Schwabl, Thomas Reiberger, Rafael Paternostro, Maria Weber, Birgit Willinger, Markus Zeitlinger	3
11	Perception of clinical research among patients and healthy volunteers of clinical trials 2022 ·European Journal of Clinical Pharmacology ·Felix Bergmann, Peter Matzneller, Maria Weber, (unknown), Thorsten Fuereder, Thomas Weber, Markus Zeitlinger	4
12	Does the circulating ketoconazole metabolite N-deacetyl ketoconazole contribute to the drug-drug interaction potential of the parent compound? 2021 ·European Journal of Pharmaceutical Sciences ·Johanna Weiß, Kathrin I. Foerster, Maria Weber, Jürgen Burhenne, Gerd Mikus, Thorsten Lehr, Walter E. Haefeli	7
13	Comparison of non-invasive Staphylococcus aureus sampling methods on lesional skin in patients with atopic dermatitis 2021 ·European Journal of Clinical Microbiology & Infectious Diseases ·Heimo Lagler, Christine Bangert, Tamara Quint, (unknown), (unknown), (unknown), Maria Weber, (unknown), Morten Otto Alexander Sommer, Markus Zeitlinger	8
14	Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects 2020 ·Clinical Pharmacology & Therapeutics ·Martin Bauer, (unknown), Verena Pichler, Maria Weber, (unknown), Alexandra Maier‐Salamon, Ammar Tahir, Walter Jäger, Helmuth Haslacher, Nicolas Tournier, Marcus Hacker, Markus Zeitlinger, Oliver Langer	19
15	Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate ¹¹C-Metoclopramide Assessed with PET Imaging in Humans 2019 ·Journal of Nuclear Medicine ·Nicolas Tournier, Martin Bauer, Verena Pichler, Lukas Nics, Eva‐Maria Klebermass, (unknown), Peter Matzneller, Maria Weber, Rudolf Karch, Fabien Caillé, Sylvain Auvity, Solène Marie, Walter Jäger, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger, Oliver Langer	38
16	Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography 2019 ·EJNMMI Research ·Beatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, Harald Stefanits, C. Philippe, Maria Weber, Thomas Czech, Marie‐Claude Menet, Xavier Declèves, Johannes A. Hainfellner, Matthias Preusser, Marcus Hacker, Markus Zeitlinger, Markus Müller, Oliver Langer	3
17	Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [¹¹C]Tariquidar and PET in Humans and Mice 2019 ·Molecular Pharmaceutics ·(unknown), Martin Bauer, Beatrix Wulkersdorfer, Alexander Traxl, C. Philippe, Maria Weber, Stéphanie Häusler, Bruno Stieger, Walter Jäger, Severin Mairinger, Thomas Wanek, Marcus Hacker, Markus Zeitlinger, Oliver Langer	19
18	A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood–Brain Barrier 2018 ·Journal of Nuclear Medicine ·Martin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, C. Philippe, Lukas Nics, Eva‐Maria Klebermass, Maria Weber, Stefan Poschner, Helmuth Haslacher, Walter Jäger, Nicolas Tournier, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger, Oliver Langer	27
19	Effect of Rifampicin on the Distribution of [¹¹C]Erlotinib to the Liver, a Translational PET Study in Humans and in Mice 2018 ·Molecular Pharmaceutics ·Martin Bauer, Alexander Traxl, Akihiro MATSUDA, Rudolf Karch, C. Philippe, Lukas Nics, Eva‐Maria Klebermass, Beatrix Wulkersdorfer, Maria Weber, Stefan Poschner, Nicolas Tournier, Walter Jäger, Wolfgang Wadsak, Marcus Hacker, Thomas Wanek, Markus Zeitlinger, Oliver Langer	16
20	Left infrarenal region: anatomic variants, pathologic conditions, and diagnostic pitfalls. 1991 ·Radiographics ·Spencer B. Gay, (unknown), Maria Weber, B Williamson	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact